The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES

被引：0
作者：
Jia, Guoqing [1 ]
Jia, Mengzhen [1 ]
Li, Chuntao [1 ]
机构：
[1] Beijing Shunyi Hosp, Dept Gastrointestinal, 3 Guangming South St, Beijing 101300, Shunyi, Peoples R China
来源：
BMC GASTROENTEROLOGY | 2024年 / 24卷 / 01期
关键词：
Dietary fiber intake; Sleep; Liver fibrosis; Metabolic dysfunction-associated steatotic liver disease; NHANES; ADULTS; APNEA;
D O I：
10.1186/s12876-024-03538-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Background Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Dietary fiber intake may improve the stimulate the secretion of sleep cytokines, inhibit the inflammatory pathway, contribute to regulating sleep disorders and alleviate liver fibrosis. The associations of dietary fiber intake, sleep patterns, with liver fibrosis remain unclear. The study aimed to explore the associations between dietary fiber, sleep, and liver fibrosis, as well as the moderating effect of dietary fiber intake between sleep patterns and liver fibrosis in MASLD patients. Methods Using data from the National Health and Nutrition Examination Survey (NHANES) database spanning from 2017 to 2020, a cross-sectional study included participants with MASLD was performed to assess the relationship between sleep patterns, dietary fiber intake, and liver fibrosis. Weighted univariate and multivariate logistic regression models were used to examine the linear connection between sleep pattern, dietary fiber intake, and liver fibrosis. Restricted cubic spline (RCS) method was also performed to describe the nonlinear relationship. A two-part linear regression model was also used to estimate threshold effects. The moderating effect of dietary fiber intake was further investigated in different subgroups. All results were presented as odds ratios (ORs) and 95% confidence intervals (CIs). Results Totally, 1343 MASLD patients were included for final analysis. Among them, 207 (15.41%) have liver fibrosis. Dietary fiber intake did not correlate significantly with sleep pattern in patients with MASLD (Spearman's r = -0.028, P = 0.1678). Poor sleep pattern was related to higher odds of liver fibrosis (OR = 3.23, 95%CI: 1.05-9.90), while dietary fiber intake >= 15 gm/day was associated with lower liver fibrosis risk (OR = 0.51, 95%CI: 0.32-0.83). On the association between sleep pattern and liver fibrosis stratified by dietary fiber intake revealed that poor sleep patterns (OR = 15.13, 95%CI: 4.40-52.01) remained associated with increased liver fibrosis risk among individuals with dietary fiber intake < 15 gm/day. No connection was observed between poor sleep patterns and liver fibrosis in MASLD patients with higher dietary fiber intake, with moderate dietary fiber supplementation beneficial in mitigating poor sleep patterns associated with liver fibrosis. The similar findings were also found in patients aged < 50 years old, >= 50 years old, females, those with and without CVD groups, hypertension, and dyslipidemia. Particularly, dietary fiber intake also moderates the relationship between sleep patterns and liver fibrosis in the F4 stage (OR = 13.26, 95%CI: 4.08-43.11). Conclusion Dietary fiber intake affects the relationship between sleep patterns and liver fibrosis in MASLD patients.
引用
收藏
页数：11
相关论文
共 45 条
  • [1] Eslam M., Sanyal A.J., George J., MAFLD: A Consensus-Driven proposed nomenclature for metabolic Associated fatty liver disease, Gastroenterology, 158, pp. 1999-e20141, (2020)
  • [2] Chan K.E., Koh T.J.L., Tang A.S.P., Quek J., Yong J.N., Tay P., Et al., Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a Meta-analysis and systematic review of 10 739 607 individuals, J Clin Endocrinol Metab, 107, pp. 2691-2700, (2022)
  • [3] Huang D.Q., El-Serag H.B., Loomba R., Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 18, pp. 223-238, (2021)
  • [4] Zhang P., Dong X., Zhang W., Wang S., Chen C., Tang J., Et al., Metabolic-associated fatty liver disease and the risk of cardiovascular disease, Clin Res Hepatol Gastroenterol, 47, (2023)
  • [5] Subramanian P., Hampe J., Tacke F., Chavakis T., Fibrogenic pathways in metabolic dysfunction Associated fatty liver Disease (MAFLD), Int J Mol Sci, 23, (2022)
  • [6] Parola M., Pinzani M., Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues, Mol Aspects Med, 65, pp. 37-55, (2019)
  • [7] Shigiyama F., Kumashiro N., Tsuneoka Y., Igarashi H., Yoshikawa F., Kakehi S., Et al., Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice, Am J Physiol Endocrinol Metab, 315, pp. E848-E858, (2018)
  • [8] Sengupta A., Rhoades S.D., Kim E.J., Nayak S., Grant G.R., Meerlo P., Et al., Sleep restriction induced energy, methylation and lipogenesis metabolic switches in rat liver, Int J Biochem Cell Biol, 93, pp. 129-135, (2017)
  • [9] Zheng J., Chen S., Cai Y., Lin S., Ke S., Liu L., Insufficient nocturnal sleep was associated with a higher risk of fibrosis in patients with diabetes with metabolic associated fatty liver disease, Ther Adv Endocrinol Metab, 11, (2020)
  • [10] Marin-Alejandre B.A., Abete I., Cantero I., Riezu-Boj J.I., Milagro F.I., Monreal J.I., Et al., Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls, Nutrients, 11, (2019)
12345